Analysis of European Biotech Companies on the Stock Markets

The BIOCOM report “Analysis of European Biotech Companies on the Stock Markets: US vs Europe” provides a complete overview of the current European public biotech sector. Ever since 2012, it covers all IPOs, follow-on financings, and secondary listings on all major stock market centres in Europe, as well as on Nasdaq. 

Download the report 2018/2 published in the European Biotechnology Magazine (PDF)

Do you want to know more? Are you ready to become part of the European biotech picture? Contact us now:

Sandra Wirsching

Divisional Director

Tel. +49-30-264921-63
E-Mail s.wirsching(at)

Latest Updates

A quick walk through the last 20 years of biotech investing in Europe and a snapshot of the state of the...


Biotech stock markets are still appreciated by investors. Whereas the number of IPOs significantly decreased...


After a healthy reset in 2016, biotech stock markets experienced a new wave of optimism with increased volumes...